These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
347 related articles for article (PubMed ID: 37033031)
1. Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease. Chen Y; Wang Y; Cui Z; Liu W; Liu B; Zeng Q; Zhao X; Dou J; Cao J Front Public Health; 2023; 11():1154837. PubMed ID: 37033031 [TBL] [Abstract][Full Text] [Related]
2. Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review. Cano R; Pérez JL; Dávila LA; Ortega Á; Gómez Y; Valero-Cedeño NJ; Parra H; Manzano A; Véliz Castro TI; Albornoz MPD; Cano G; Rojas-Quintero J; Chacín M; Bermúdez V Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062716 [TBL] [Abstract][Full Text] [Related]
3. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease. Polyzos SA; Kountouras J; Deretzi G; Zavos C; Mantzoros CS Curr Mol Med; 2012 Jan; 12(1):68-82. PubMed ID: 22082482 [TBL] [Abstract][Full Text] [Related]
4. Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease. Deierlein AL; Rock S; Park S Curr Environ Health Rep; 2017 Dec; 4(4):439-449. PubMed ID: 28980219 [TBL] [Abstract][Full Text] [Related]
5. The association between endocrine disrupting chemicals and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Pan K; Xu J; Xu Y; Wang C; Yu J Pharmacol Res; 2024 Jul; 205():107251. PubMed ID: 38862070 [TBL] [Abstract][Full Text] [Related]
6. Association between endocrine-disrupting chemical mixtures and non-alcoholic fatty liver disease with metabolic syndrome as a mediator among adults: A population-based study in Korea. Park B; Kim B; Kim CH; Oh HJ; Park B Ecotoxicol Environ Saf; 2024 May; 276():116310. PubMed ID: 38614002 [TBL] [Abstract][Full Text] [Related]
7. Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease. Treviño LS; Katz TA Endocrinology; 2018 Jan; 159(1):20-31. PubMed ID: 29126168 [TBL] [Abstract][Full Text] [Related]
8. Chemical Effect of Bisphenol A on Non-Alcoholic Fatty Liver Disease. Dallio M; Diano N; Masarone M; Gravina AG; Patanè V; Romeo M; Di Sarno R; Errico S; Nicolucci C; Abenavoli L; Scarpellini E; Boccuto L; Persico M; Loguercio C; Federico A Int J Environ Res Public Health; 2019 Aug; 16(17):. PubMed ID: 31466361 [TBL] [Abstract][Full Text] [Related]
11. Environmental exposures to endocrine disrupting chemicals (EDCs) and their role in endometriosis: a systematic literature review. Sirohi D; Al Ramadhani R; Knibbs LD Rev Environ Health; 2021 Mar; 36(1):101-115. PubMed ID: 32903210 [TBL] [Abstract][Full Text] [Related]
12. The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey. Lei R; Xue B; Tian X; Liu C; Li Y; Zheng J; Luo B Ecotoxicol Environ Saf; 2023 May; 256():114836. PubMed ID: 37001192 [TBL] [Abstract][Full Text] [Related]
13. Impact of endocrine-disrupting chemicals on neural development and the onset of neurological disorders. Kajta M; Wójtowicz AK Pharmacol Rep; 2013; 65(6):1632-9. PubMed ID: 24553011 [TBL] [Abstract][Full Text] [Related]
14. Endocrine-Disrupting Chemicals and Disorders of Penile Development in Humans. Gaspari L; Tessier B; Paris F; Bergougnoux A; Hamamah S; Sultan C; Kalfa N Sex Dev; 2021; 15(1-3):213-228. PubMed ID: 34438394 [TBL] [Abstract][Full Text] [Related]
15. Environmental non-persistent endocrine-disrupting chemicals exposure and reproductive hormones levels in adult men. Dziewirska E; Hanke W; Jurewicz J Int J Occup Med Environ Health; 2018 Oct; 31(5):551-573. PubMed ID: 30228382 [TBL] [Abstract][Full Text] [Related]
16. Application of In Vitro Models for Studying the Mechanisms Underlying the Obesogenic Action of Endocrine-Disrupting Chemicals (EDCs) as Food Contaminants-A Review. Kowalczyk M; Piwowarski JP; Wardaszka A; Średnicka P; Wójcicki M; Juszczuk-Kubiak E Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674599 [TBL] [Abstract][Full Text] [Related]
17. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156 [TBL] [Abstract][Full Text] [Related]
18. Endocrine-disrupting chemicals: Effects on neuroendocrine systems and the neurobiology of social behavior. Gore AC; Krishnan K; Reilly MP Horm Behav; 2019 May; 111():7-22. PubMed ID: 30476496 [TBL] [Abstract][Full Text] [Related]
19. Early-life exposure to endocrine disrupting chemicals associates with childhood obesity. Yang C; Lee HK; Kong APS; Lim LL; Cai Z; Chung ACK Ann Pediatr Endocrinol Metab; 2018 Dec; 23(4):182-195. PubMed ID: 30599479 [TBL] [Abstract][Full Text] [Related]
20. Endocrine-disrupting chemicals in ovarian function: effects on steroidogenesis, metabolism and nuclear receptor signaling. Craig ZR; Wang W; Flaws JA Reproduction; 2011 Nov; 142(5):633-46. PubMed ID: 21862696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]